REQUEST A DEMO
Total
USD $0.00
Search more companies

Millimed Bfs Company Limited (Thailand)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Millimed Bfs Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Millimed Bfs Company Limited is a company in Thailand, with a head office in Chiang Rai. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. Millimed Bfs Company Limited was incorporated on July 06, 2026. It currently has a total number of 250 (estimated) employees. The latest financial highlights indicate a net sales revenue increase of 64.82% in 2025. Its’ total assets recorded a growth of 61.95%. The net profit margin of Millimed Bfs Company Limited increased by 13.08% in 2025.

Headquarters
174,179 Moo 8
Chiang Rai; Northern Thailand; Postal Code: 57210

Contact Details: Purchase the Millimed Bfs Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Millimed Bfs Company Limited report to view the information.
Financial Auditors:
Purchase the Millimed Bfs Company Limited report to view the information.
Incorporation Date:
July 06, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Millimed Bfs Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
64.82%
Total Operating Revenue
64.32%
Operating Profit
135.03%
Net Profit/Loss for the Period
140.21%
Total Assets
61.95%
Total Equity
70.83%
Operating Profit Margin
12.85%
Net Profit Margin
13.08%
Return on Equity (ROE)
11.98%
Debt / Equity
-18.68%
Quick Ratio
0.54%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?